President Donald Trump’s announcement on tariffs for imported pharmaceutical goods has been delayed again, despite earlier claims it would come “very soon.” Reuters reports the decision may still be weeks away, as U.S. officials weigh the impact.
Trump’s Pharma Tariff Decision Faces New Delay
Swiss leaders met with Roche and Novartis executives to discuss potential fallout, especially after the U.S. imposed a 39% tariff on Switzerland last month.
Trump recently signed an executive order to stockpile key medicines and has floated tariffs reaching 250%. The delay may be tied to an ongoing Section 232 investigation, which could grant authority to impose tariffs if national security risks are found.
Follow us on:
Read More News at #latestmalaysia #BusinessNews and #WorldFuture
